Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03311126
Title Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

mantle cell lymphoma

Therapies

Bendamustine + Obinutuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.